Agios (AGIO) Q2 2025 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]
Agios (AGIO) Q3 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Agios Pharmaceuticals (AGIO) had its price target lowered by Bank of America Corporation from $44.00 to $41.00. They now have a "buy" rating on the stock.
Here's Why Agios Pharmaceuticals Crashed 23% Today [Globe and Mail, The (Toronto, Canada)]
Agios Pharmaceuticals (AGIO) had its price target lowered by HC Wainwright from $65.00 to $50.00. They now have a "buy" rating on the stock.